Erratum: Improving the validity of determining medication adherence from electronic health record medications orders (Journal of the American Medical Informatics Association (2011) 18 (717-20) DOI: 10.1136/amiajnl-2011-000151);Improving the validity of determining medication adherence from electronic health record medications orders

Journal of the American Medical Informatics Association

Volumn 18, Issue 5, 2011, Pages 717-720

  Carroll, Nikki M ^a   Ellis, Jennifer L ^a   Luckett, Capp F ^a   Raebel, Marsha A ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ARTICLE; COMPUTERIZED PROVIDER ORDER ENTRY; ELECTRONIC MEDICAL RECORD; MEDICAL INFORMATION SYSTEM; MEDICATION ORDER; PATIENT COMPLIANCE; PATIENT SELECTION; PHARMACY; PRESCRIPTION;

EID: 80053283492     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1093/jamia/ocw147     Document Type: Erratum

References (17)

1. Balkrishnan R. The importance of medication adherence in improving chronicdisease related outcomes: what we know and what we need to further know. Med Care 2005;43:517-20.
2. Osterberg L, Blaschkte T. Adherence to medication. N Engl J Med 2005;353:497.
3. Walker EA, Molitch M, Kramer MK, et al. Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program. Diabetes Care 2006;29:1997-2002.
4. Wu JR, Moser DK, DeJong MJ, et al. Defining an evidence-based cutpoint for medication adherence in heart failure. Am Heart J 2009;157:285-91.
5. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-30.
6. Ho PM, Magid DJ, Shetterly SM, et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med 2008;168:271-6.
7. McGinnis BD, Olson KL, Delate TM, et al. Statin adherence and mortality in patients enrolled in a secondary prevention program. Am J Manag Care 2009;15:689-95.
8. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006;166:1836-41.
9. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006;166:1842-7.
10. Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006;15:565-74.
11. Hess LM, Raebel MA, Conner DA, et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006;40:1280-8.
12. Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:455-61.
13. Shah NR, Hirsch AG, Zacker C, et al. Factors associated with first-fill adherence rates for diabetic medications: a cohort study. J Gen Intern Med 2008;24:233-7.
14. Shah NR, Hirsch AG, Zacker C, et al. Predictors of first-fill adherence for patients with hypertension. Am J Hypertens 2009;22:392-6.
15. Mork JG, Bodenreider O, Demner-Fushman D, et al. Extracting Rx information from clinical narrative. J Am Med Inform Assoc 2010;17:536-9.
16. Turchin A, Wheeler HI, labreche M, et al. Indentification of documented medication non-ahderence in physician notes. Proceedings of the American Medical Informatics Association Symposium. Washington, DC, 2008:732-6.
17. Fischer MA, Stedman MR, Lii J, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med 2010;25:284-90.